← Leaderboards
Martin Miguel Conda Sheridan
University Of Nebraska Medical Center
$1,395,480
Attributed
$1,395,480
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $410.7K · FY2016–25$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,395,480 · 3
By mechanism
P20$834,267 · 1
R01$410,713 · 1
R03$150,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Stephen Obaro$4,097,128
- Siwei Zhao$1,981,061
- Alexander V Kabanov$28,176,125
- Sophie Alvarez$176,746
Others in their field
Top investigators on “Light Scattering”
- Jeffrey R Kuhn · University Of Hawaii$72,803,786
- Michael T Knoelker · Association Of Universities For Research In Astronomy, Inc.$72,474,426
- Robert Rosner · University Of Wisconsin-Madison$72,474,426
- Philip Goode · New Jersey Institute Of Technology$72,474,426
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$72,474,426
- Keith O Hodgson · Stanford University$27,882,258
Research focus
Light ScatteringAtomic Force MicroscopyToxic EffectWaterReportingNanostructuresShapesStructureBindingNanofiberDesignMorphologyIn VivoIn VitroAffinityLigandsNanocarrierFiberBaseEffective TherapyAntineoplastic AgentsEncapsulatedMass Spectrum AnalysisBlood Circulation
Grant awards (6)
Theory Assisted Design, Synthesis and Biological Activity of Bacteria-Targeting Nanostructures$410,713
R01 · FY2025 · EB · contact PI
Developing Targeted Therapeutic Nanosystems to Treat Metastatic Colon Cancer$279,075
P20 · FY2020 · GM · contact PI
Developing Targeted Therapeutic Nanosystems to Treat Metastatic Colon Cancer$279,075
P20 · FY2019 · GM · contact PI
Developing Targeted Therapeutic Nanosystems to Treat Metastatic Colon Cancer$276,117
P20 · FY2018 · GM · contact PI
Towards an Effective Prostate Cancer-Targeting Biomaterial$75,250
R03 · FY2017 · EB · contact PI
Towards an Effective Prostate Cancer-Targeting Biomaterial$75,250
R03 · FY2016 · EB · contact PI